Onyx is a dynamic company and is guided by many years of pharmaceutical experience.

As a result we are ideally placed to meet the needs of the fast moving pharmaceutical marketplace without compromising quality.

Tony Flinn - CEO Dr Tony Flinn is Chief Executive Officer and founder of Onyx. Tony holds a PhD in synthetic organic chemistry and has extensive experience in both pure and applied chemistry. Tony has worked for a number of companies in a variety of roles and brings a wealth of experience to the job of CEO. Contact Tony at tonyflinn@onyx-scientific.com. Denise Bowser - Commercial Director Denise is a founding member of Onyx and is responsible for commercial operations. She previously worked for Chirex where she gained several years experience as a Development Chemist and Product Manager. Contact Denise at denisebowser@onyx-scientific.com. Andrew Henderson - Business Development Manager Andrew previously worked as a Chemist at Onyx before moving into business development. Andrew studied for his PhD in medicinal chemistry at the University of Newcastle upon Tyne. Contact Andrew at andrewhenderson@onyx-scientific.com. Craig Mason - Business Development Manager Craig obtained a PhD in synthetic organic chemistry from the University of Durham in 2003. After graduating, he gained several years experience working for a speciality chemicals company in a range of technical and commercial roles. Contact Craig at craigmason@onyx-scientific.com.

Dr. Derek Londesbrough - R&D Director

Derek is responsible for R&D operations at Onyx and brings with him more than 10 years experience in the pharmaceutical and fine chemical industry. He has previously worked for Chirex, CPL Aromas and Contrachem. Derek's main areas of expertise are in route discovery and selection, process development and scale up.

Dr. Julian Northen - Research Manager

Julian is Onyx's principal medicinal chemist and is responsible for lead optimisation services at Onyx. Having worked in both the UK and USA in a variety of therapeutic areas Julian brings an important level of expertise and experience to Onyx.

Dr. Doug Henderson - Chemical Development Manager

Doug is a founding member and highly experienced development chemist. Having gained more than 25 years experience of chemical development and organic synthesis with Chirex, Doug is closely involved in all aspect of process optimisation at Onyx.

Simon Olley - Analytical Manager

Simon is a founding member having previously being responsible for analytical activities with Chirex. Simon brings with him more than 10 years experience and leads Onyx's specialist team of analysts.

Dr Philippe Fernandes - Solid State Scientist

Philippe worked for six years as a PDRA at the Strathclyde Institute of Pharmacy and Biomedical Sciences in Glasgow, where he specialised in crystallographic investigations of pharmaceuticals. Philippe joined Onyx to support and develop the company’s solid-state service offering.

Dave Waldram - Operations and Safety Manager

Dave is a founding member of the company and brings with him more than 25 years experience in chemical development and pharmaceutical manufacturing. He is responsible for kilo scale production and safety operations at Onyx.

David Ansell - Quality Assurance Manager

David is responsible for Onyx's quality assurance program which encompasses everything from analytical procedures to full GMP batch release. He brings with him more than 20 years experience in pharmaceutical quality management and GMP production.